Company Profile - BANGKOK DUSIT MEDICAL SERVICES PUBLIC COMPANY LIMITED

Company Profile BANGKOK DUSIT MEDICAL SERVICES PUBLIC COMPANY LIMITED

Please enter search criteria

Search Company

BANGKOK DUSIT MEDICAL SERVICES PUBLIC COMPANY LIMITED

Sustainability Development Ranking

CG Score ^1/

CG Score

AGM Level ^2/

AGM Score

Thai-CAC ^3/

Thai CAC ^3/
n/a

Thailand Sustainability Investment ^4/

Thailand Sustainability Investment
THSI (SET) and DJSI

Ranking by Industry

Business ^4/

Business

The Company operates in the large private hospital business with networks in Thailand and Cambodia. The Company operates under 6 hospital groups, namely, Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group and Royal Hospital Group. In addition, the Company?s network also covers businesses that support medical care such as medical laboratories, medicine production and saline production.

Top 10 Major Shareholders(@10 Mar 2022)		Share	%
1.	MR. PRASERT PRASARTTHONGOSOT	2,037,626,440	12.82
2.	บริษัท Thai NVDR Company Limited	1,524,449,562	9.59
3.	บริษัท วิริยะประกันภัย จำกัด (มหาชน)	930,563,830	5.86
4.	บริษัท การบินกรุงเทพ จำกัด (มหาชน)	828,418,690	5.21
5.	น.ส. ปรมาภรณ์ ปราสาททองโอสถ	807,377,610	5.08
6.	SOUTH EAST ASIA UK (TYPE C) NOMINEES LIMITED	612,597,805	3.85
7.	สำนักงานประกันสังคม	610,956,500	3.84
8.	UBS AG SINGAPORE BRANCH	593,201,402	3.73
9.	นาย จิโรจน์ สุชาโต	374,991,090	2.36
10.	STATE STREET EUROPE LIMITED	298,935,868	1.88

Management		Position
1.	Mr. SANTASIRI SORNMANI	CHAIRMAN OF THE BOARD OF DIRECTORS / INDEPENDENT DIRECTOR
2.	Miss PORAMAPORN PRASARTTONG-OSOTH	CHAIRPERSON OF THE EXECUTIVE COMMITTEE / PRESIDENT / DIRECTOR
3.	Mr. CHULADEJ YOSSUNDHARAKUL	VICE CHAIRMAN
4.	Mrs. NARUMOL NOI-AM	DIRECTOR
5.	Mr. SRIPOP SARASAS	DIRECTOR
6.	Mr. PRADIT THEEKAKUL	DIRECTOR
7.	Mr. THONGCHAI JIRA-ALONGKORN	DIRECTOR
8.	Mr. ATT THONGTANG	DIRECTOR
9.	Mr. PUTTIPONG PRASARTTONG-OSOTH	DIRECTOR
10.	Mr. CHAIRAT PANTHURAAMPHORN	DIRECTOR
11.	Mr. PRASERT PRASARTTONG-OSOTH	DIRECTOR
12.	Mr. CHAVALIT SETHAMETEEKUL	INDEPENDENT DIRECTOR / CHAIRMAN OF THE AUDIT COMMITTEE
13.	Mr. WEERAWONG CHITTMITTRAPAP	INDEPENDENT DIRECTOR / AUDIT COMMITTEE
14.	Mr. KAN TRAKULHOON	INDEPENDENT DIRECTOR
15.	Mr. VEERATHAI SANTIPRABHOB	INDEPENDENT DIRECTOR / AUDIT COMMITTEE
16.	Mr. PREDEE DAOCHAI	INDEPENDENT DIRECTOR
17.	Mr. SUBHAK SIWARAKSA	INDEPENDENT DIRECTOR

Company Profile ^4/

Field name	Detail
Address	2 SOI SOONVIJAI 7, NEW PETCHABURI ROAD, BANGKAPI, HUAY KWANG Bangkok10310
Phone	0-2310-3000
Fax	0-2318-1546 , 0-2310-3327
URL	www.bangkokhospital.com

Contact Person

Contact	Contact Name
ฝ่ายผู้ลงทุนสัมพันธ์	-
เลขานุการบริษัท	นางสาวเกษรา วงศ์เกตุ

Company News

Information Disclosure

ข้อมูลผลิตภัณฑ์

Filing

Other Information

Financial Statements (Concise Version) ^5/

Full Version

Statement of Comprehensive Income (MB.)	3M/2022 (01/01/22 -31/03/22)	3M/2021 (01/01/21 -31/03/21)	2021 (01/01/21 -31/12/21)	2020 (01/01/20 -31/12/20)	2019 (01/01/19 -31/12/19)
Accounting Type	Consolidate	Consolidate	Consolidate	Consolidate	Consolidate
Revenue From Operations	22,985.93	16,027.42	74,451.35	68,074.08	82,722.64
Other Income	173.00	253.47	1,262.62	983.06	1,051.19
Total Revenues	23,171.50	16,294.25	75,791.68	69,101.64	83,893.22
Costs	14,450.84	11,050.56	49,461.96	46,371.18	54,276.72
Selling And Administrative Expenses	4,024.83	3,283.88	15,028.62	14,160.90	17,446.57
Total Cost And Expenses	18,475.67	14,334.44	64,490.58	60,532.08	71,723.29
EBITDA	6,194.79	3,543.54	17,643.50	17,684.30	26,271.02
Depre. & Amor.	1,490.13	1,580.85	6,321.29	6,412.75	5,459.65
EBIT	4,704.66	1,962.68	11,322.21	11,271.55	20,811.38
Net Profit : Owners Of The Parent	3,443.03	1,338.66	7,936.08	7,214.24	15,517.17
EPS (B.)	0.22	0.08	0.50	0.45	0.99

Statement of Cash Flow (MB.)	3M/2022 (01/01/22 -31/03/22)	3M/2021 (01/01/21 -31/03/21)	2021 (01/01/21 -31/12/21)	2020 (01/01/20 -31/12/20)	2019 (01/01/19 -31/12/19)
Accounting Type	Consolidate	Consolidate	Consolidate	Consolidate	Consolidate
Operating Cash Flow	5,146.74	4,007.80	14,560.94	11,681.27	14,546.09
Investing Cash Flow	-2,144.90	-1,102.42	-4,763.08	12,385.35	2,817.94
Financing Cash Flow	-2,636.21	-206.01	-18,530.57	-9,096.47	-17,701.33
Net Cash Flow	365.64	2,699.37	-8,732.71	14,970.15	-337.31

Statement of Financial Position (MB.)	3M/2022 (01/01/22 -31/03/22)	3M/2021 (01/01/21 -31/03/21)	2021 (01/01/21 -31/12/21)	2020 (01/01/20 -31/12/20)	2019 (01/01/19 -31/12/19)
Accounting Type	Consolidate	Consolidate	Consolidate	Consolidate	Consolidate
Cash And Cash Equivalents	11,299.29	22,365.73	10,933.66	19,666.37	4,696.21
A/R Net	11,025.85	6,151.04	9,130.75	7,191.78	8,850.03
Inventories	1,939.04	1,646.61	2,004.94	1,855.17	1,843.37
Current Assets	27,175.82	31,668.03	24,401.39	30,012.80	16,325.19
PP&E Net	79,506.19	80,839.40	79,689.15	84,628.06	79,461.67
Non-Current Assets	103,922.10	105,341.29	104,052.22	106,037.45	117,336.55
Total Assets	131,097.92	137,009.32	128,453.62	136,050.25	133,661.74
OD	-	-	-	-	23.80
A/P Net	5,074.26	3,936.34	5,034.56	4,450.04	5,990.18
Current portion of LT	4,599.49	2,499.53	3,099.89	107.47	5,193.25
Current Liabilities	18,886.89	13,368.52	15,862.00	11,220.35	19,263.15
Non-Current Liabilities	20,915.53	30,799.44	24,826.69	33,367.20	27,216.96
Total Liabilities	39,802.41	44,167.96	40,688.69	44,587.55	46,480.11
Authorized Capital	1,758.22	1,758.22	1,758.22	1,758.22	1,758.22
Paid-Up Capital	1,589.20	1,589.20	1,589.20	1,589.20	1,589.20
Premium (Discount) on Share Capital	30,166.10	30,166.10	30,166.10	30,471.10	30,166.10
Retained Earnings (Deficit)	46,391.72	48,606.13	42,948.69	47,275.35	45,883.82
Treasury Stock	-	-	-	-	-
Shares Of The Company Held By Subsidiaries	-	-	-	-	-
Other Components Of Equity	9,170.83	8,938.05	9,141.20	8,574.53	6,174.31
- Surplus (Deficits)	-2,393.25	305.00	-2,393.38	-2,699.61	-2,693.62
Shareholders' Equity	87,317.85	89,299.48	83,845.19	87,910.18	83,813.43
Minority Interest	3,977.65	3,541.87	3,919.74	3,552.51	3,368.19

Accumulated: Turnover Ratio, Value Trade/Day
Statistics	YTD 19 May 2022	2021 30 Dec 2021	2020 30 Dec 2020
Listed share (M.)	15,892.00	15,892.00	15,892.00
Market Cap (MB.)	425,111.05	365,516.04	330,553.64
Price (B./share)	26.75	23.00	20.80
BVPS (B./Share)	5.49	5.08	5.22
P/BV (X)	4.87	4.53	3.98
P/E (X)	42.34	47.54	46.24
Turnover Ratio (%)	28.37	50.97	54.04
Value Trade/Day (MB.)	1,232.85	749.70	758.02
Beta	0.32	0.60	0.98

Rate of Return	YTD	2021	2020
Price Change (%)	16.30	10.58	-20.00
Dividend Yield (%)	1.68	2.39	2.64
Payout Ratio	0.71	1.65	0.67
Dividend Policy	No less than 50% of the net profit of the consolidated financial statements (with addtional conditions)

¹CG Score 2021 from Thai Institute of Directors Association (IOD)
²AGM Level 2021 from Thai Investors Association
³Companies participating in Thailand's Private Sector Collective Action Coalition Against Corruption programme (Thai CAC) under Thai Institute of Directors (as of May 9, 2022) are categorised into:

companies that have declared their intention to join CAC, and
companies certified by CAC.

⁴The Stock Exchange of Thailand : the record of listed companies with corporate sustainable development "Thai sustainability Investment 2021" included:

SET and mai listed companies passed the assessment conducted by the Stock Exchange of Thailand: THSI (SET) and THSI (mai)
SET listed companies passed the assessment conducted by the Dow Jones Sustainability Indices (DJSI)

⁵Financial Data / Company Business / Address / Major Shareholders / Management / Business News / Opportunity day belongs to The Stock Exchange of Thailand.
Website users agree and acknowledge that the copyright for it is The SET and can be used for education or only private investment. In cases where the data commercially, Please contact Information Services Department, The Stock Exchange of Thailand e-mail : infoproducts@set.or.th